Allergic asthma, allergic rhinitis, rash...Only the right medicine can better prevent and treat allergic diseases. The advanced products brought by the world's Fortune 500 enterprise Thermo Fisher are related to allergy treatment. Eastday.com's reporter interviewed Tony Acciarito, President of Thermo Fisher China, trying to find out how helpful the new products of the company can improve people's health.

Thermo Fisher’s booth at the Medical Devices and Healthcare exhibition area

As an old friend of the CIIE, Thermo Fisher made its debut in the medical devices and health care exhibition area and public health and epidemic prevention zone in the form of double booths for the first time this year, focusing on 70 core products, of which more than 20 are new products to be launched in 2020. Among the core products displayed by Thermo Scientific Phadia 250 for allergen detection, one of the core products attracted the interest of many visitors and stopped: Thermo Scientific Phadia 250 fully automated fluorescence immunoassay analyzer for allergen detection.

Thermo Scientific Phadia 250 fully automated fluorescence immunoassay analyzer

What is the right thing to do to detect allergies? According to Thermo Fisher's technical experts, prevention and treatment of allergic diseases, the first thing is to correctly diagnose what kind of allergy it is. At present, allergen specific IgE detection by extracting blood for analysis is a commonly used method in vitro detection. IgE (serum immunoglobulin E) is an antibody of human body. The specific IgE (SiGe) corresponding to different allergens. For example, you can determine whether you are allergic to milk by measuring the concentration of specific IgE in your body. Through the solution of Thermo Fisher Phadia series, specific IgE can be accurately and quantitatively analyzed, which can provide correct guidance for doctors in clinical diagnosis and better control and treatment of allergic symptoms. It is worth mentioning that Phadia's exclusive patent is immunocap Gamma The system is also recommended by the European Society of allergy and clinical immunology as the "gold standard" for in vitro diagnosis of allergic diseases.

Thermo Fisher's booth at the Public Health and Epidemic Prevention zone

In terms of the building of public security system to assist in the regular epidemic prevention and control, Thermo Fisher's related exhibits are also full of highlights. According to Acciarito, products such as cryoEM can help scientists observe the structure of the virus at the first time in the early stage of the outbreak, laying the foundation for virus prevention and vaccine development. In terms of virus sample extraction, virus nucleic acid detection and virus sequence determination, Thermo Fisher has brought its new Amplitude™ High-throughput automated detection platform for novel coronavirus nucleic acid, which has the ability to detect 7000 new coronavirus samples every day, which can effectively improve the detection efficiency of virus nucleic acid and let everyone get the test results faster. At the same time, the mobile shelter nucleic acid testing laboratory displayed in the public health and epidemic prevention zone will help implement and implement the national large-scale screening program, and accelerate the nucleic acid detection capacity of disease control institutions at and above the county level and general hospitals above the second level.

In addition, at this fair, Thermo Fisher also announced that it had formally signed a joint venture project agreement with Innoforce, a bio innovation driven enterprise, to jointly establish a new biopharmaceutical CDMO joint venture factory in Hangzhou to integrate the development and production of biological solutions and sterile preparations. The joint venture project is expected to be officially completed in 2022, "This new joint venture factory will become an important part of thermo global pharmaceutical service network. The plant will be equipped with leading technology to assist drug development, biological preparation production, aseptic filling, packaging and logistics of clinical trial samples. "Acciarito told reporter.

Tony Acciarito, President of Thermo Fisher China

Talking about the experience and harvest of participating in the Expo for three consecutive years and his views on China's economy, Acciarito said: "thanks to China's long-term adherence to the open policy and the constantly optimized business environment, thermo has been operating in China for nearly 40 years. Under the new development pattern of mutual promotion of domestic and international dual circulation, thermo has deepened the exchange and cooperation with the local market through the platform of China International Fair for three consecutive years. " In recent years, the continuous investment in the development of biopharmaceuticals, laboratory construction and localization cooperation has also confirmed the confidence and expectation of Thermo Fisher in the Chinese market. On September 25 this year, Thermo Fisher invested more than US $10 million to expand the Suzhou factory of its China manufacturing center and set up its Suzhou innovation center. On October 20, Thermo Fisher’s globally largest customer experience center settled in Zhangjiang, Shanghai.

At the end of the interview, Acciarito said that China is the second largest market in the world, and the company will accelerate its development in China in the future.